Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) posted quarterly Other Working Capital Changes of -$203000.0 for Q1 2026, up 97.61% year-over-year from -$102728.1 in Q1 2025, and up 89.28% quarter-over-quarter from -$1.9 million in Q4 2025.
Maravai Lifesciences Holdings (MRVI) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$203000.0 for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 97.61% year-over-year to -$203000.0; the TTM figure through Mar 2026 stood at -$10.3 million (up 24.16% YoY), while the FY2025 annual figure was -$18.6 million, down 195.78% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at -$203000.0, up from -$1.9 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $26.3 million in Q3 2022, with the low at -$21.3 million in Q2 2023.
- The 5-year median for Other Working Capital Changes is -$439000.0 (2024), against an average of $2.0 million.
- Peak annual rise in Other Working Capital Changes reached 12217.19% in 2025, while the deepest fall reached 638.26% in 2025.
- Maravai Lifesciences Holdings' Other Working Capital Changes stood at -$2.7 million in 2022, then soared by 40.04% to -$1.6 million in 2023, then increased by 29.88% to -$1.2 million in 2024, then tumbled by 64.61% to -$1.9 million in 2025, then surged by 89.28% to -$203000.0 in 2026.
- Business Quant data shows MRVI's Other Working Capital Changes at -$203000.0 in Q1 2026, -$1.9 million in Q4 2025, and -$16.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Maravai Lifesciences Holdings | 1.48 Bn | 1.56 Bn | 20.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 771,000.00 |
| Jun 30, 2026 | 771,000.00 |
| Jun 30, 2026 | 771,000.00 |
| Mar 31, 2026 | -1.43 Mn |
| Mar 31, 2026 | -1.43 Mn |
| Mar 31, 2026 | -1.43 Mn |
| Dec 31, 2025 | 264,000.00 |
| Dec 31, 2025 | 264,000.00 |
| Dec 31, 2025 | 264,000.00 |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Jun 30, 2025 | 2.86 Mn |
| Mar 31, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.24 Mn |
| Mar 31, 2025 | -2.24 Mn |
| Dec 31, 2024 | 817,000.00 |
| Dec 31, 2024 | 817,000.00 |